Important presenter information

This page includes the information you need to make sense of the Congress programme. It also includes all the information you need on types of presentation, presentation length, format and upload method. 

If your abstract has been accepted, you will be invited to come to WMS 2026 as a poster presenter (printed or ePoster), short oral presenter, oral presenter or late-breaking oral or poster presenter. If you are registered to attend the Congress virtually and have had your abstract accepted, you will be invited to submit a virtual poster and a video presentation, which will be available within our virtual platform and app. If you are a poster presenter, you will receive your P, eP or VP number by email in due course. This is your poster number. If you are an oral presenter, your confirmation email will include an O number. If you are a short oral presenter, your confirmation email will include an SP number. This is your presentation number. You can check the Congress programme for your P, eP, VP, SP or O number to find out when you are presenting. The full programme will be available in June 2026.

As well as the information on this page, if you are invited to give an oral presentation, we recommend you review our tip sheet for additional guidance.

Programme key and presentation prefixes

INV = Invited speaker
O/LBO = Oral presenter/late-breaking oral presenter
P/SP/LBP = Poster presenter/poster highlights presenter/late breaking poster presenter/short oral presenter (on display at the venue and on the virtual platform. Short oral presenters will only have a virtual version of their poster on the virtual platform and on the app and ePoster screens in the venue. During the four poster sessions, they will not need to stand by their ePoster)
eP = ePoster presenter (on display on electronic screens and in the virtual platform and app)
VP/LBVP = Virtual poster presenter/ late-breaking virtual poster presenter (on display on the virtual platform and on ePoster screens at the venue)

1.01P for example represents poster session 1, and then poster 01 in that session.

Clicking on either of the images will open the grid as a pdf.

Programme details

Details of these sessions will be published as an appendix to the full Congress programme. Please check the Congress programme for your presentation details:

• Refer to the Summary Congress Programme; or
• Refer to the Full Congress Programme (available from June).

Once you have located your P, eP, SP, VP or O number in your notification email, search the PDF (CTRL+F) or scroll up slowly to find the date, time, and other presentation details.

CME Accreditation

WMS 2026 Poster Sessions, Short Oral Presentations, Clinical Trial Updates and Industry Symposia are not EACCME accredited. Please refer to the information on our Certificate of Attendance page for further information on accreditation.

Community engagement

Whether you're presenting virtually or in-person, you can use the messaging service within our virtual platform and Congress app to connect with other delegates. As a presenter, it is important that you check whether other delegates are trying to get in touch with you to discuss your work. The virtual platform and Congress app will go live a few days before the Congress opens.

Conflict of interest

All faculty, Programme Committee members, Local Organising Committee members and oral presenters must disclose any conflicts of interest.

We will contact you if you need to complete a conflict of interest form.

At the Congress, all speakers must disclose any conflict of interest both verbally and with a slide at the beginning of their presentation. Video recordings for virtual presenters must include a disclosure screen at the beginning of the recording and posters must display disclosures in the bottom left or right corner.

Examples of relationships that should be disclosed include, but are not limited to:

• Any direct financial payments including receipt of honoraria;
• Membership on the advisory board or speakers’ bureaus;
• Funded grants or clinical trials;
• Patents on a drug, product or device; and
• All other investments or relationships which could be seen by a reasonable, well-informed participant as having the potential to influence the content of the educational activity.

If none of these criteria applies to you, you should inform the audience that you have nothing to disclose. As the presenter, it is your responsibility to make sure your conflict of interest disclosure is accurate at the time of the presentation.

Deadlines

You can find all key deadlines on the dates page.

Evidence-based approach

Speakers must use the best available evidence to support their content.

• Examples include systematic reviews, meta-analyses, or literature reviews;
• Any lack of evidence for assertions must be acknowledged;
• If a single study is highlighted or others are omitted, a rationale must be provided;
• Graphs and charts must not be altered to emphasise a specific treatment or product;
• Both benefits and potential harms should be discussed; and
• Presenters should use metrics such as number needed to treat (NNT), number needed to harm (NNH), and absolute and relative risk reduction.

Publication consent

During registration, presenters will be asked whether they consent to having their recorded presentation, poster, or video made available:

• on the virtual platform for up to three months post-event
• on the WMS website and social media for members to access later

If you do not consent, your content will be available only during the Congress and removed within two weeks following the Congress.

Important Contacts

Speaker Manager: [email protected]
Abstract Manager: [email protected]

Terms and conditions

Abstract submission terms and conditions. The submitted abstract must not:

• contains libellous, unlawful or otherwise actionable matter;
• infringe any copyright or violate any other intellectual property or privacy right of any person or entity.

**Consent for Post-Course/Congress use of presentation recordings
Registration
Code of Conduct